Description

Albunorm 20% Solution for Infusions 50 ml. №1 Vial

Ingredients:

Albunorm 20% solution contains human albumin as the active ingredient. It is a sterile, non-pyrogenic solution obtained from human plasma.

Dosage:

The dosage of Albunorm 20% solution is determined by the healthcare provider based on the patient’s condition, weight, and medical history. It is administered intravenously and should be given slowly to prevent adverse reactions.

Indications:

Albunorm 20% solution is indicated for the restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated.

Contraindications:

Do not use Albunorm 20% solution if the patient has a history of hypersensitivity to albumin or any component of the formulation. It is contraindicated in patients with severe anemia and heart failure.

Directions:

Follow the healthcare provider’s instructions carefully when using Albunorm 20% solution. The solution should be inspected visually for particulate matter and discoloration before administration.

Scientific Evidence:

Studies have shown that Albunorm 20% solution is effective in treating hypovolemia and improving hemodynamic stability in critically ill patients. Research published in the Journal of Intensive Care supports the use of albumin solutions for volume resuscitation in sepsis.

Additional Information:

Albunorm 20% solution should be stored at controlled room temperature and protected from light. It is essential to monitor the patient for signs of fluid overload during administration.

Albunorm 20% solution works by increasing plasma volume and improving oncotic pressure in the blood vessels, which helps to maintain adequate tissue perfusion. This pharmacological action is crucial in conditions where there is a loss of intravascular volume, such as in septic shock or major surgeries.

Clinical trials have demonstrated the comparative effectiveness of Albunorm 20% solution against crystalloid solutions in critically ill patients. A meta-analysis published in Critical Care Medicine showed that albumin solutions were associated with a lower risk of mortality compared to crystalloids in certain patient populations.